2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...
»ï¼ºÀüÀÚ, °¡Á¤¿ë ½Ã½ºÅÛ¿¡¾îÄÁ 5¿ù ÆÇ¸Å 25% Áõ°¡ (2024-06-22)
Toshiba Releases Digital Isolators that Contribute to Stable... (2023-05-10)
¡®´©±¸³ª °¡Á×°ø¿¹ ¿¹¼ú°¡°¡ µÉ ¼ö ÀÖ´Ù¡¯ Ãâ°£ (2024-03-01)
Áøµ¾°³ÀÇ ³¯¡¤¾î¸°À̳¯, °­¾ÆÁö½£¼­ Áñ±â¼¼¿ä (2024-05-01)
¼Û»êµµ¼­°ü, ³ëÀÎÀ» À§ÇÑ Æ¯È­ ÀÚ·á °ø°£ Á¶¼º (2024-01-09)
µ¶ÀÏ ¸¶ÀÏ·¹ ¡®³ª³ëÇ÷¯½º ÇÏÀ̺긮µå ¿ÍÀÌÆÛ¡¯ (2016-04-13)
½Å¿ùµ¿ ±èÆ÷°¡¾ÐÀå, ¿¹¼ú±³À°Àü¿ë°ø°£À¸·Î Àç»ý (2016-10-07)
¡®µ¹º½¡¯ °³³ä ´ëµÎµÇ¸ç µ¹º½ Á¶¸íÇÏ´Â µµ¼­µé Ãâ°£ (2024-05-04)
½Ì¾î¼Û¶óÀÌÅÍ Ç³³â, µ¥ºß ½Ì±Û ¡®ÇØ¿î´ë¹ã¹Ù´Ù¡¯ ¹ß¸Å (2015-08-12)
Hartree Partners (UK) Ltd. Acquires a 50% Share in Biomethan... (2024-03-13)
SKÅÚ·¹ÄÞ, ¿Â¶óÀÎ ¿ä±ÝÁ¦ °³Æí... °í°´ °¡Ä¡ Á¦°í (2022-12-14)
Sharp, Motorola Mobility, and Kyocera Join Access Advance¡¯s... (2023-02-10)
¡®ºÒ²É¹êµå¡¯ »ç¶û°ú ÆòÈ­, 1~4¶ó¿îµå ´©Àû ¼øÀ§ Áý°è ¡®1À§¡¯ (2023-09-27)
Japan Sake and Shochu Makers Association Will Hold an Event ... (2024-07-07)
±ÝȣŸÀ̾î, Áö¼Ó°¡´ÉÇÑ ¿øÀç·á 80% Àû¿ë Á¦Ç° °³¹ß (2023-11-27)
Biocytogen Launches ¡°Nano 100 Project¡± to Develop Fully Hu... (2023-02-22)
NetApp and AWS Deliver a Nine Times Performance Increase for... (2023-11-30)
´ºº£À̽º, ¡®¸ÞµðÅ©·ç¡¯ ¸ð¹ÙÀÏ ¾Û ·ÐĪ (2023-04-21)
»ó¹Ý±â ½ÇÀû°ø»çºñ ´Ü°¡ Æò±Õ 1.9% »ó½Â (2014-02-28)
MSCI Appoints Luke Flemmer to Lead and Expand Private Assets... (2024-11-03)
¹öÃß¾ó ÈÞ¸Õ ¹× º¸Äà AI Á¦ÀÛ ¾÷¹«Çù¾à (2023-12-06)
Á¤¼º²É¹è´Þ, 700¿© È­¿ø»ç¿Í ÅëÇÕ ²É¹è´Þ ¼­ºñ½º (2023-10-12)
KKR, 64¾ï´Þ·¯ ±Ô¸ð ¡®¾Æ½Ã¾Æ ÅÂÆò¾ç ÀÎÇÁ¶ó II ÆÝµå¡¯ ¸ðÁý (2024-02-02)
¾Ö´ÏÆæ, AI¡¤AR Àû¿ëÇÑ ¹®È­Àç XR Ç÷§Æû °ø°³ (2023-12-09)
Æ®·ÎÆ®°¡¼ö ¼³¿îµµ ÆÐ·¯µðÇÑ '´ÙÇÔ²² ÄíÂ÷Â÷' (2014-12-08)
       [ÀÌÀü][1]....[832][833][834][835][836][837][838][839][840]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..